Singapore markets close in 1 hour 32 minutes
Straits Times Index
3,319.52 +11.62 (+0.35%) Nikkei
39,103.22 +486.12 (+1.26%) Hang Seng
18,935.22 -260.38 (-1.36%) FTSE 100
8,360.27 -10.06 (-0.12%) Bitcoin USD
69,515.93 -157.17 (-0.23%) CMC Crypto 200
1,514.67 +12.01 (+0.80%)
Aurobindo Pharma Limited (AUROPHARMA.BO)
BSE - BSE Real-time price. Currency in INR
Add to watchlist
As of 12:42PM IST. Market open.
Currency in INR
Valuation measures4
| Market cap (intra-day) | 716.46B |
| Enterprise value | 708.57B |
| Trailing P/E | 25.94 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 2.60 |
| Price/book (mrq) | 2.55 |
| Enterprise value/revenue | 2.57 |
| Enterprise value/EBITDA | 12.57 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.58 |
| 52-week change 3 | 102.53% |
| S&P500 52-week change 3 | 27.84% |
| 52-week high 3 | 1,231.20 |
| 52-week low 3 | 593.85 |
| 50-day moving average 3 | 1,104.24 |
| 200-day moving average 3 | 1,002.66 |
Share statistics
| Avg vol (3-month) 3 | 48.9k |
| Avg vol (10-day) 3 | 59.65k |
| Shares outstanding 5 | 585.94M |
| Implied shares outstanding 6 | 586.54M |
| Float 8 | 279.78M |
| % held by insiders 1 | 52.07% |
| % held by institutions 1 | 32.60% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 4.5 |
| Forward annual dividend yield 4 | 0.37% |
| Trailing annual dividend rate 3 | 4.50 |
| Trailing annual dividend yield 3 | 0.37% |
| 5-year average dividend yield 4 | 0.69 |
| Payout ratio 4 | 12.70% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 20 Feb 2024 |
| Last split factor 2 | 2:1 |
| Last split date 3 | 20 Jul 2015 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Mar 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 9.93% |
| Operating margin (ttm) | 16.02% |
Management effectiveness
| Return on assets (ttm) | N/A |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 278.95B |
| Revenue per share (ttm) | 475.61 |
| Quarterly revenue growth (yoy) | 14.70% |
| Gross profit (ttm) | N/A |
| EBITDA | 48.94B |
| Net income avi to common (ttm) | 27.7B |
| Diluted EPS (ttm) | 47.30 |
| Quarterly earnings growth (yoy) | 90.60% |
Balance sheet
| Total cash (mrq) | 71.49B |
| Total cash per share (mrq) | 122.47 |
| Total debt (mrq) | 66.49B |
| Total debt/equity (mrq) | 23.58% |
| Current ratio (mrq) | N/A |
| Book value per share (mrq) | 477.64 |
Cash flow statement
| Operating cash flow (ttm) | N/A |
| Levered free cash flow (ttm) | N/A |
© 2024 Yahoo. All rights reserved.